Review
Glyminox Biosyn
Affiliations
- PMID: 15043398
Item in Clipboard
Review
Glyminox Biosyn
Curr Opin Investig Drugs.
2004 Feb.
Abstract
Glyminox (Savvy) is a vaginal gel formulation of C31G being developed by Biosyn as a potential contraceptive and for the potential prevention of transmission of sexually transmitted diseases, including HIV infection. In March 2002, glyminox was in phase II/III trials for Chlamydia treatment and as a contraceptive, and in phase II trials for herpes simplex virus shedding.
Similar articles
-
PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.Curr Opin Investig Drugs. 2008 Feb;9(2):189-200. Curr Opin Investig Drugs. 2008. PMID: 18246522
-
Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.Contraception. 2007 Oct;76(4):314-8. doi: 10.1016/j.contraception.2007.05.092. Epub 2007 Aug 28. Contraception. 2007. PMID: 17900444
-
"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.Am J Public Health. 2006 Jun;96(6):1073-7. doi: 10.2105/AJPH.2004.047514. Epub 2006 May 2. Am J Public Health. 2006. PMID: 16670239 Free PMC article.
-
AIDSVAX VaxGen.Curr Opin Investig Drugs. 2004 Feb;5(2):214-21. Curr Opin Investig Drugs. 2004. PMID: 15043397 Review.
-
ONO-2506. Ono.Curr Opin Investig Drugs. 2003 Jul;4(7):863-7. Curr Opin Investig Drugs. 2003. PMID: 14619409 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical